Drug intelligence / Profile preview

sufentanil + ropivacaine

Development stage
Unknown
Lead developer
Peking University First Hospital
Modality
Small Molecules
Administration
Epidural
01

Overview

Sufentanil + ropivacaine is a combination of a potent synthetic opioid analgesic and a long-acting amide-type local anesthetic. It is commonly used for epidural labor analgesia to provide effective pain relief during childbirth. Sufentanil acts as a highly selective agonist at the mu-opioid receptor, providing systemic and neuraxial analgesia. Ropivacaine works by reversibly blocking sodium channels in nerve fibers, inhibiting the conduction of nerve impulses. In clinical research conducted by Peking University First Hospital, this combination is often utilized as a standard of care comparator for evaluating novel analgesic regimens like dexmedetomidine-esketamine-ropivacaine.

Other names
sufentanil-ropivacaine combination
02

Targets

NaV (Voltage-gated sodium channels)MOR (Mu opioid receptor)

Beyond the preview

Go deeper on sufentanil + ropivacaine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on sufentanil + ropivacaine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call